Lansen Pharmaceutical Holdings Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Lansen Pharmaceutical Holdings Limited with three other
companies in this sector in China:
Chengdu Taihe Health Technology Group Inc Ltd
sales of 590.95 million Chinese Renmimbi [US$84.94 million]
of which 86%
was Medicine Manufacturing),
Chongqing Pharscin Pharmaceutical Co LtdChongqing Pharscin Pharmaceutical Co L td
(592.10 million Chinese Renmimbi [US$85.11 million]
of which 82%
was Medicine Industry), and
Ningbo Menovo Pharmaceutical Co Ltd
(605.32 million Chinese Renmimbi [US$87.01 million]
of which 84%
was Pharmaceutical manufacture).
During the year ended December of 2017, sales at
Lansen Pharmaceutical Holdings Limited were 602.67 million Chinese Renmimbi (US$86.63 million).
decrease of 4.5%
versus 2016, when the company's sales were 630.90 million Chinese Renmimbi.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Lansen Pharmaceutical Holdings Limited had sales
of 591.37 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 33.8% decline
in Healthcare Products, from 81.94 million Chinese Renmimbi to 54.28 million Chinese Renmimbi.
There were also decreases in sales in
Medical Cosmetics Produts (down 26.0% to 88.87 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Specialty Pharmaceuticals (up 7.1% to 459.52 million Chinese Renmimbi)